Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004636
Filing Date
2021-11-15
Accepted
2021-11-15 16:58:12
Documents
108
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dna-20210930.htm   iXBRL 10-Q 4744801
2 EX-31.1 dna-ex31_1.htm EX-31.1 18444
3 EX-31.2 dna-ex31_2.htm EX-31.2 18045
4 EX-32.1 dna-ex32_1.htm EX-32.1 10630
5 EX-32.2 dna-ex32_2.htm EX-32.2 11119
  Complete submission text file 0000950170-21-004636.txt   16791314

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dna-20210930_def.xml EX-101.DEF 532135
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dna-20210930_cal.xml EX-101.CAL 59676
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dna-20210930_lab.xml EX-101.LAB 728618
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20210930.xsd EX-101.SCH 100673
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dna-20210930_pre.xml EX-101.PRE 698208
11 EXTRACTED XBRL INSTANCE DOCUMENT dna-20210930_htm.xml XML 3165476
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40097 | Film No.: 211411995
SIC: 2836 Biological Products, (No Diagnostic Substances)